These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 14643298)
41. In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs. Munsimbwe L; Seetsi A; Namangala B; N'Da DD; Inoue N; Suganuma K Molecules; 2021 Jun; 26(11):. PubMed ID: 34199682 [TBL] [Abstract][Full Text] [Related]
42. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance. Bernhard SC; Nerima B; Mäser P; Brun R Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691 [TBL] [Abstract][Full Text] [Related]
43. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48. Martínez-García M; Bart JM; Campos-Salinas J; Valdivia E; Martínez-Bueno M; González-Rey E; Navarro M; Maqueda M; Cebrián R; Pérez-Victoria JM Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):203-212. PubMed ID: 29649664 [TBL] [Abstract][Full Text] [Related]
44. Differential virulence of Trypanosoma brucei rhodesiense isolates does not influence the outcome of treatment with anti-trypanosomal drugs in the mouse model. Ndung'u K; Murilla GA; Thuita JK; Ngae GN; Auma JE; Gitonga PK; Thungu DK; Kurgat RK; Chemuliti JK; Mdachi RE PLoS One; 2020; 15(11):e0229060. PubMed ID: 33151938 [TBL] [Abstract][Full Text] [Related]
45. Drug resistance in human African trypanosomiasis. Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143 [TBL] [Abstract][Full Text] [Related]
46. [Melarsoprol]. Simon F Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741 [No Abstract] [Full Text] [Related]
47. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo. Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944 [TBL] [Abstract][Full Text] [Related]
48. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482 [TBL] [Abstract][Full Text] [Related]
49. Identification and characterization of trypanocides by functional expression of an adenosine transporter from Trypanosoma brucei in yeast. Mäser P; Vogel D; Schmid C; Räz B; Kaminsky R J Mol Med (Berl); 2001 Apr; 79(2-3):121-7. PubMed ID: 11357935 [TBL] [Abstract][Full Text] [Related]
50. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985]. Pérez Martín O; Lastre González M; Urban M; Shwalbach J Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188 [TBL] [Abstract][Full Text] [Related]
51. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Heby O; Persson L; Rentala M Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127 [TBL] [Abstract][Full Text] [Related]
52. An alternative form of melarsoprol in sleeping sickness. Kennedy PG Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910 [TBL] [Abstract][Full Text] [Related]
53. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis. Vodnala SK; Lundbäck T; Yeheskieli E; Sjöberg B; Gustavsson AL; Svensson R; Olivera GC; Eze AA; de Koning HP; Hammarström LG; Rottenberg ME J Med Chem; 2013 Dec; 56(24):9861-73. PubMed ID: 24283924 [TBL] [Abstract][Full Text] [Related]
54. The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes. de Koning HP; Anderson LF; Stewart M; Burchmore RJ; Wallace LJ; Barrett MP Antimicrob Agents Chemother; 2004 May; 48(5):1515-9. PubMed ID: 15105099 [TBL] [Abstract][Full Text] [Related]
55. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines. Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078 [TBL] [Abstract][Full Text] [Related]
56. Chemotherapy of human African trypanosomiasis: current and future prospects. Fairlamb AH Trends Parasitol; 2003 Nov; 19(11):488-94. PubMed ID: 14580959 [No Abstract] [Full Text] [Related]
57. Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus. Lecordier L; Uzureau P; Tebabi P; Brauner J; Benghiat FS; Vanhollebeke B; Pays E Mol Microbiol; 2015 Aug; 97(3):397-407. PubMed ID: 25899052 [TBL] [Abstract][Full Text] [Related]
58. [Human African trypanosomiasis]. Dumas M; Bouteille B C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890 [TBL] [Abstract][Full Text] [Related]
59. Targeting of toxic compounds to the trypanosome's interior. Barrett MP; Gilbert IH Adv Parasitol; 2006; 63():125-83. PubMed ID: 17134653 [TBL] [Abstract][Full Text] [Related]
60. Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis. Ettari R; Previti S; Maiorana S; Amendola G; Wagner A; Cosconati S; Schirmeister T; Hellmich UA; Zappalà M J Med Chem; 2019 Dec; 62(23):10617-10629. PubMed ID: 31714776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]